Welcome to CYTAVIS BioPharma GmbH

CYTAVIS, based in Bergisch-Gladbach/Germany, is a product driven oncology company with a focus on natural compounds. The company’s portfolio comprises pre-clinical and clinical programs.

Latest News

ASCO Annual Meeting 2009

Read more …

2009-05-12 by Prof. Dr. Lentzen

Phase II trial with Aviscumine (CY-503): Metastatic Melanoma

CYTAVIS BioPharma is currently conducting a phase II trial with Aviscumine (CY-503) in patients with metastatic melanoma (stage IV).

Read more …

2009-04-01 by Administrator